Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA refuses review of mRNA flu vaccine

Digest more
Top News
Overview
Reasons
 · 2d · on MSN
FDA won’t review Moderna application for first mRNA-based flu vaccine
The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.

Continue reading

 · 6h
FDA refuses to review Moderna's mRNA flu shot
 · 18h
FDA Declines to Review Moderna’s mRNA Flu Vaccine Application
Scientific American · 1d
FDA won’t consider a new mRNA vaccine for flu, despite the technology’s life-saving promise
The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

Continue reading

 · 1d
Moderna says FDA refuses its application for new mRNA flu vaccine
 · 9h
FDA defends its decision to refuse review of Moderna's flu vaccine
 · 1d
F.D.A. Refuses to Review Moderna Flu Vaccine
Dr. Vinay Prasad, the agency’s top vaccine regulator, rejected the company’s application for approval over a concern that Moderna’s clinical trial had compared its experimental vaccine against a produ...

Continue reading

 · 1d
FDA refuses to review Moderna’s mRNA flu vaccine application
 · 2d
Moderna says FDA refuses to review its application for flu vaccine
Insider Media
23m

First mRNA vaccine manufactured in UK approved by regulators

The first mRNA vaccine to be manufactured in the UK has been approved by regulators. The UK Medicines and Healthcare products Regulatory Agency (MHRA) has given Moderna's Covid-19 mRNA vaccine Spikevax the go-ahead in time for this year's NHS vaccine campaign.
1d

FDA refuses Moderna's application for new mRNA flu vaccine

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Healio
13h

More data show mRNA COVID-19 vaccination during pregnancy is safe

The messenger RNA COVID-19 vaccine is not tied to neurodevelopmental disorders in youth whose mothers who were vaccinated immediately before or during pregnancy, data show.The study, presented at The Pregnancy Meeting and “conducted through a rigorous scientific process in an NIH clinical trials network,
1d

Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

The biotech announced Tuesday evening that in a rare move, the Food and Drug Administration won’t review its application for a mRNA-based flu vaccine over concerns about the choice of vaccine tested against the experimental vaccine in Phase 3 clinical trials. Moderna described the FDA as “inconsistent” in its communications.
1d

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna

Related topics

Moderna
FDA
Food and Drug Administration
  • Privacy
  • Terms